
Gadoxetate Disodium
CAS No. 135326-22-6
Gadoxetate Disodium( Gd-EOB-DTPA Disodium,ZK 139834 )
Catalog No. M22181 CAS No. 135326-22-6
Gadoxetate Disodium is used to evaluate focal liver lesions, such as hepatocellular carcinoma or liver metastasis on T1-weighted imaging.
Purity : >98% (HPLC)






Size | Price / USD | Stock | Quantity |
2MG | 33 | In Stock |
![]() ![]() |
5MG | 53 | In Stock |
![]() ![]() |
10MG | 87 | In Stock |
![]() ![]() |
25MG | 161 | In Stock |
![]() ![]() |
50MG | 286 | In Stock |
![]() ![]() |
100MG | 426 | In Stock |
![]() ![]() |
200MG | Get Quote | In Stock |
![]() ![]() |
500MG | Get Quote | In Stock |
![]() ![]() |
1G | Get Quote | In Stock |
![]() ![]() |
Biological Information
-
Product NameGadoxetate Disodium
-
NoteResearch use only, not for human use.
-
Brief DescriptionGadoxetate Disodium is used to evaluate focal liver lesions, such as hepatocellular carcinoma or liver metastasis on T1-weighted imaging.
-
DescriptionGadoxetate Disodium is used to evaluate focal liver lesions, such as hepatocellular carcinoma or liver metastasis on T1-weighted imaging. It is a contrast agent in magnetic resonance imaging (MRI) of the hepatobiliary system. It accumulates in normal, functioning hepatocytes.
-
In Vitro——
-
In Vivo——
-
SynonymsGd-EOB-DTPA Disodium,ZK 139834
-
PathwayOthers
-
TargetOther Targets
-
RecptorOthers
-
Research AreaOthers
-
IndicationTransient Severe Arterial Phase Motion
Chemical Information
-
CAS Number135326-22-6
-
Formula Weight725.71
-
Molecular FormulaC23H28GdN3Na2O11
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?H2O : ≥ 100 mg/mL (137.80 mM))
-
SMILES[Na+].[Na+].[Gd+3].CCOc1ccc(CC(CN(CCN(CC([O-])=O)CC([O-])=O)CC([O-])=O)N(CC([O-])=O)CC([O-])=O)cc1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Schuhmann-Giampieri G, et al. Preclinical evaluation of Gd-EOB-DTPA as a contrast agent in MR imaging of the hepatobiliary system. Radiology. 1992 Apr;183(1):59-64.
molnova catalog



related products
-
HAE
HAE is a 3-amino acid peptide composed of histidine, alanine and glutamate.
-
T-900607
T-900607 is a novel microtubule protein active agent that disrupts microtubule polymerization through a unique mechanism of action. t-900607 is cardiotoxic.
-
Skp2 inhibitor 1
Skp2 inhibitor 1 is a Skp2-Cks1 interaction inhibitor (IC50: 2.8μM) with antitumor activity and can be used to study cancer.